{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-279776","form_type":"8-K","ticker":"CPRX","cik":"0001369568","company_name":"CATALYST PHARMACEUTICALS, INC.","filed_at":"2026-06-23T21:15:09+00:00","discovered_at":"2026-06-23T21:16:00.195763+00:00","generated_at":"2026-06-23T21:16:33.138498+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"FTC grants early termination of HSR waiting period for Catalyst-Angelini merger","bullets":["FTC early termination of HSR Act waiting period granted June 16; Catalyst aware June 22.","Closing still requires majority shareholder approval and other customary conditions.","Parties expect deal to close in Q3 2026.","Catalyst shareholders to vote on merger as detailed in definitive proxy statement filed June 8."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-279776","json":"https://secwatch.observer/filing/0001193125-26-279776.json","markdown":"https://secwatch.observer/filing/0001193125-26-279776.md","text":"https://secwatch.observer/filing/0001193125-26-279776.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1369568/000119312526279776/0001193125-26-279776-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1369568/000119312526279776/d166178d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T21:16:33.138498+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}